Article Versions Notes

Kalsum S, Xu R, Akber M, Huang S, Lerm M, Chen Y, Lourda M, Zhou Y, Brighenti S. Dual GSK-3β/HDAC Inhibitors Enhance the Efficacy of Macrophages to Control Mycobacterium tuberculosis Infection. Biomolecules. 2025; 15(4):550. https://doi.org/10.3390/biom15040550

Kalsum, Sadaf, Ruilan Xu, Mira Akber, Shengjie Huang, Maria Lerm, Yuqing Chen, Magda Lourda, Yang Zhou, and Susanna Brighenti. 2025. "Dual GSK-3β/HDAC Inhibitors Enhance the Efficacy of Macrophages to Control Mycobacterium tuberculosis Infection" Biomolecules 15, no. 4: 550. https://doi.org/10.3390/biom15040550

Kalsum, S., Xu, R., Akber, M., Huang, S., Lerm, M., Chen, Y., Lourda, M., Zhou, Y., & Brighenti, S. (2025). Dual GSK-3β/HDAC Inhibitors Enhance the Efficacy of Macrophages to Control Mycobacterium tuberculosis Infection. Biomolecules, 15(4), 550. https://doi.org/10.3390/biom15040550